|
|
(One intermediate revision not shown.) |
Line 3: |
Line 3: |
| <StructureSection load='4qqx' size='340' side='right'caption='[[4qqx]], [[Resolution|resolution]] 3.34Å' scene=''> | | <StructureSection load='4qqx' size='340' side='right'caption='[[4qqx]], [[Resolution|resolution]] 3.34Å' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[4qqx]] is a 8 chain structure with sequence from [http://en.wikipedia.org/wiki/Thefy Thefy]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QQX OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4QQX FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[4qqx]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/Thermobifida_fusca_YX Thermobifida fusca YX]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QQX OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4QQX FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ATP:ADENOSINE-5-TRIPHOSPHATE'>ATP</scene>, <scene name='pdbligand=FE:FE+(III)+ION'>FE</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.34Å</td></tr> |
- | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4qqw|4qqw]], [[4qqz|4qqz]]</td></tr> | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ATP:ADENOSINE-5-TRIPHOSPHATE'>ATP</scene>, <scene name='pdbligand=FE:FE+(III)+ION'>FE</scene></td></tr> |
- | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">Tfu_1593 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=269800 THEFY])</td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4qqx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qqx OCA], [https://pdbe.org/4qqx PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4qqx RCSB], [https://www.ebi.ac.uk/pdbsum/4qqx PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4qqx ProSAT]</span></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qqx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qqx OCA], [http://pdbe.org/4qqx PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4qqx RCSB], [http://www.ebi.ac.uk/pdbsum/4qqx PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4qqx ProSAT]</span></td></tr> | + | |
| </table> | | </table> |
| + | == Function == |
| + | [https://www.uniprot.org/uniprot/Q47PJ0_THEFY Q47PJ0_THEFY] |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
Line 21: |
Line 22: |
| ==See Also== | | ==See Also== |
| *[[CRISPR type I-E (Cascade)|CRISPR type I-E (Cascade)]] | | *[[CRISPR type I-E (Cascade)|CRISPR type I-E (Cascade)]] |
- | *[[Endonuclease|Endonuclease]] | + | *[[Endonuclease 3D structures|Endonuclease 3D structures]] |
- | *[[Helicase|Helicase]] | + | *[[Helicase 3D structures|Helicase 3D structures]] |
| == References == | | == References == |
| <references/> | | <references/> |
Line 28: |
Line 29: |
| </StructureSection> | | </StructureSection> |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Thefy]] | + | [[Category: Thermobifida fusca YX]] |
- | [[Category: Huo, Y]] | + | [[Category: Huo Y]] |
- | [[Category: Ke, A]] | + | [[Category: Ke A]] |
- | [[Category: Nam, K H]] | + | [[Category: Nam KH]] |
- | [[Category: Cas3]]
| + | |
- | [[Category: Crispr]]
| + | |
- | [[Category: Helicase]]
| + | |
- | [[Category: Helicase-dna complex]]
| + | |
- | [[Category: Hydrolase]]
| + | |
- | [[Category: Hydrolase-dna complex]]
| + | |
| Structural highlights
Function
Q47PJ0_THEFY
Publication Abstract from PubMed
CRISPR drives prokaryotic adaptation to invasive nucleic acids such as phages and plasmids, using an RNA-mediated interference mechanism. Interference in type I CRISPR-Cas systems requires a targeting Cascade complex and a degradation machine, Cas3, which contains both nuclease and helicase activities. Here we report the crystal structures of Thermobifida fusca Cas3 bound to single-stranded (ss) DNA substrate and show that it is an obligate 3'-to-5' ssDNase that preferentially accepts substrate directly from the helicase moiety. Conserved residues in the HD-type nuclease coordinate two irons for ssDNA cleavage. We demonstrate ATP coordination and conformational flexibility of the SF2-type helicase domain. Cas3 is specifically guided toward Cascade-bound target DNA by a PAM sequence, through physical interactions with both the nontarget substrate strand and the CasA protein. The sequence of recognition events ensures well-controlled DNA targeting and degradation of foreign DNA by Cascade and Cas3.
Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation.,Huo Y, Nam KH, Ding F, Lee H, Wu L, Xiao Y, Farchione MD Jr, Zhou S, Rajashankar K, Kurinov I, Zhang R, Ke A Nat Struct Mol Biol. 2014 Aug 17. doi: 10.1038/nsmb.2875. PMID:25132177[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Huo Y, Nam KH, Ding F, Lee H, Wu L, Xiao Y, Farchione MD Jr, Zhou S, Rajashankar K, Kurinov I, Zhang R, Ke A. Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation. Nat Struct Mol Biol. 2014 Aug 17. doi: 10.1038/nsmb.2875. PMID:25132177 doi:http://dx.doi.org/10.1038/nsmb.2875
|